AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Switglim-M 1/500 Tablet

Prescription Icon
Prescription Required

Marketer

Akumentis Healthcare Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Switglim-M 1/500 Tablet

Diabex Duo 1/500, a dual-action antidiabetic medication, manages type 2 diabetes in adults. This formulation combines two glucose-regulating agents to maintain healthy blood sugar levels. Administer Diabex Duo 1/500 with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood glucose monitoring. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to dangerously elevated glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication is one element of a comprehensive diabetes management plan, incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifesting as sweating, dizziness, headache, or tremors. Maintain regular mealtimes and carry a fast-acting glucose source, like fruit juice or candy, to counteract hypoglycemia. Alcohol consumption elevates hypoglycemia risk and should be minimized. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is possible. Contraindicated in type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of heart disease before commencing treatment. Pregnant or lactating individuals require physician consultation prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Primary Ingredients of Switglim-M 1/500 Tablet

No text provided. Please provide the text you want me to rephrase.

Uses of Switglim-M 1/500 Tablet

Managing type 2 diabetes

Major Benefits of Switglim-M 1/500 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Switglim-M 1/500 Tablets should be administered with a meal.

Common Side effects of Switglim-M 1/500 Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Switglim-M 1/500 Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Switglim-M 1/500 Tablets should be administered with a meal.

How Switglim-M 1/500 Tablet works:

Switglim-M 1/500 tablets contain Glimepiride and Metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Switglim-M 1/500 Tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Switglim-M 1/500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should not use Switglim-M 1/500 Tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Switglim-M 1/500 Tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Switglim-M 1/500 Tablets are contraindicated in patients exhibiting severe kidney disease. Regular assessment of kidney function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when administering Switglim-M 1/500 Tablets to individuals with hepatic impairment; dosage modifications may be necessary. Consult a physician. For patients experiencing mild to moderate liver dysfunction, initiate Switglim-M 1/500 Tablet therapy with a low dose; however, its use is contraindicated in cases of severe liver disease.

What if you forget to take Switglim-M 1/500 Tablet :

Should you forget a Switglim-M 1/500 Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Switglim-M 1/500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Switglim-M 1/500 Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication safely and ensure it's inaccessible to children, pets, and others.
Switglim-M 1/500 Tablets can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue use and seek immediate medical attention.
Switglim-M 1/500 tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication enhances blood glucose control when used with a healthy diet and regular exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. It's not suitable for type 1 diabetes.
Switglim-M 1/500 Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged Switglim-M 1/500 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Switglim-M 1/500 Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Switglim-M 1/500 tablets and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Switglim-M 1/500 Tablet
61
MRP 70
13% off